Go Back, Jack, Do it Again: Reissue and Reexam Patent Law 4.28.08.

Slides:



Advertisements
Similar presentations
MELISSA ASFAHANI Patent Attorney El Paso, TX
Advertisements

By David W. Hill AIPLA Immediate Past President Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Overview of the America Invents Act.
AIPLA PRESENTATION FOR USPTO PUBLIC HEARING ON REEXAMINATION Q. TODD DICKINSON AIPLA EXECUTIVE DIRECTOR JUNE 1,
1 Reissue Applications: Information and Best Practices Steve Marcus Senior Legal Advisor Office of Patent Legal Administration.
© Kolisch Hartwell 2013 All Rights Reserved, Page 1 America Invents Act (AIA) Implementation in 2012 Peter D. Sabido Intellectual Property Attorney Kolisch.
1 Recent Case Law: NARROWING/BROADENING REISSUES Bennett Celsa TC1600 Quality Assurance Specialist 6/4/13.
Joint Meeting of PIPLA and NJIPLA February 7, 2012 Kenneth N. Nigon RatnerPrestia 1.
April 24, 2012 Benoît Castel Young & Thompson U.S. Patent Law Reform Summary of H.R. 1249, “Leahy-Smith America Invents Act”
UNITED STATES PATENT AND TRADEMARK OFFICE A full transcript of this presentation can be found under the “Notes” Tab. Claim Interpretation: Broadest Reasonable.
1 Rule 132 Declarations and Unexpected Results Richard E. Schafer Administrative Patent Judge Board of Patent Appeals and Interferences.
1 1 1 AIPLA American Intellectual Property Law Association USPTO Updates Including Glossary Pilot Program Chris Fildes Fildes & Outland, P.C. IP Practice.
G & B Seminar 2006 Duty of Disclosure for Enforceable/Valid U.S. Patents Daniel Moon.
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
Post-Issuance Proceedings Under the AIA Thomas F. Cotter Briggs and Morgan Professor of Law University of Minnesota Law School.
BIPC.COM STRATEGIC CONSIDERATIONS OF POST ISSUANCE PATENTABILITY REVIEW: THE NEW, OLD, AND NO LONGER Presented By: Todd R. Walters, Esq. B UCHANAN, I NGERSOLL.
Robert M. Hansen The Marbury Law Group PLLC AIPLA Practical Patent Prosecution Training for New Lawyers August 2009Alexandria, VA Issuance, Term, Certificates.
Administrative Trials
America Invents Act (AIA) Changes in Patent Law That Impact Companies May Mowzoon: Mowzoon Law Office, PLLC 1.
Appeal Practice Before Board of Patent Appeals and Interferences
Filing Compliant Reexam Requests Andy Kashnikow SPE, Central Reexamination Unit Andy Kashnikow SPE, Central Reexamination Unit June, 2010.
AMERICA INVENTS ACT A Look Into The Future
POST-GRANT AMENDMENT JOHN RICHARDS 23 rd Annual Fordham Intellectual Property Law & Policy Conference Cambridge, April 8-9, 2015.
Reissue Practice Robert W
Greg H. Gardella Ex Parte and Inter Partes Reexamination Tactics AIPLA 2010 Winter Institute.
Safekeeping of 35 U.S.C. 156 Extensions
Patent Term Adjustment (Bio/Chem. Partnership) Kery Fries, Sr. Legal Advisor Phone: (571)
by Eugene Li Summary of Part 3 – Chapters 8, 9, and 10
Willfulness, Reissue and Reexam Prof Merges Nov. 17, 2011.
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
Patents 101 April 1, 2002 And now, for something new, useful and not obvious.
Willfulness, Reissue and Reexam Prof Merges Nov. 18, 2010.
1 REISSUE OVERVIEW 35 USC Filing Requirements 2. Oaths or Declarations 3. Grounds for Filing 4. Consent 5. Limitations 6. Recapture.
1 BROADENING REISSUES Bennett Celsa TC1600 Quality Assurance Specialist.
The U.S. Patent System is Changing – A Summary of the New Patent Reform Law.
AIA Strategies.
IP Gespräche 2009 Frankfurt ● Karlsruhe ● Basel ● Zürich Strategic Uses of U.S. Reexamination Proceedings – Strengthen Your Market Position and Avoid U.S.
Information Disclosure Statements
December 8, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818)(upon enactment) and 35 U.S.C. 103(c) as Amended by.
February 19, Recent Changes and Developments in USPTO Practice Prepared by: Office of Patent Legal Administration (OPLA) Robert J. Spar, DirectorJoni.
Anthony Venturino MILANO 10 February 2012 SELECTED PROVISIONS OF THE LEAHY Smith AMERICA INVENTS ACT OF 2011 AIPPI - AIPLA 1 © AIPLA
Remy Yucel Director, CRU (571) Central Reexamination Unit and the AIA.
1 EXAMINER’S REASONS FOR ALLOWANCE Samson Helfgott Director of Patents KMZ Rosenman New York, N.Y. January, To Respond, or not to Respond?
Impact of US AIA: What Really Changed? 1 © AIPLA 2015.
1 Patent Law in the Age of IoT The Landscape Has Shifted. Are You Prepared? 1 Jeffrey A. Miller, Esq.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
Post-Grant & Inter Partes Review Procedures Presented to AIPPI, Italy February 10, 2012 By Joerg-Uwe Szipl Griffin & Szipl, P.C.
Appeals in patent examination and opposition in Germany Karin Friehe Judge, Federal Patent Court, Munich, Germany.
Practice Before the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences.
1 Rules of Practice Before the BPAI in Ex Parte Appeals 73 Fed. Reg (June 10, 2008) Effective December 10, Fed. Reg (June 10, 2008)
© 2004 VOSSIUS & PARTNER Opposition in the Procedural System by Dr. Johann Pitz AIPPI Hungary, June 2 – 4, 2004 Kecskemét.
Reexamination at the USPTO Robert A. Clarke Deputy Director Office of Patent Legal Administration USPTO Robert A. Clarke Deputy Director Office of Patent.
PTO’s Proposals Regarding Amendments Permitted During Reexamination (A6/A7) Nancy J. Linck, Esq. Rothwell, Figg, Ernst & Manbeck June 1,
New Ex Parte Appeal Rules Patent and Trademark Practice Group Meeting January 26, 2012.
3 rd Party Participation Bennett Celsa TC 1600 QAS.
© COPYRIGHT DICKSTEIN SHAPIRO LLP. ALL RIGHTS RESERVED. Post Grant Proceedings Before the USPTO and Litigation Strategies Under the AIA Panelists:David.
Examining Claims for Compliance with 35 U.S.C. 112(a): Part II – Enablement Focus on Electrical/Mechanical and Computer/Software-related Claims August.
Biotechnology/Chemical/Pharmaceutical Customer Partnership Topic: Biotechnology/Chemical/Pharmaceutical Customer Partnership Topic: Biological Deposits.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
Prosecution Group Luncheon September, America Invents Act Passed House and Senate (HR 1249) Presidential Signature expected Friday Most provisions.
Double Patenting Deborah Reynolds SPE Art Unit 1632 Detailee, TC1600 Practice Specialist
Overview of the FTC’s 2003 Proposed Reforms to U.S. Patent Law David W. Hill.
Willfulness, Reissue and Reexam Prof Merges Nov. 15, 2012.
1 1 AIPLA 1 1 American Intellectual Property Law Association USPTO Post-Grant Procedures and Effective Use of Reissue AIPLA IP Practice in Japan Committee.
Prosecution Group Luncheon March, S.23: Patent Reform Act of 2011 Senate passed 95-5 (3/8); no House action as yet First to File Virtual (Internet)
PTAB Litigation 2016 Part 6 – Patent Owner Response 1.
The Impact of Patent Reform on Independent Inventors and Start-up Companies Mark Nowotarski (Patent Agent)
1 TOPIC III - PATENT INVALIDATION PROCEDURES EU-CHINA WORKSHOP ON THE CHINESE PATENT LAW HARBIN, SEPTEMBER 2008 Dr. Gillian Davies.
Recent Developments in Obtaining and Enforcing Intellectual Property Rights in Nanocomposites Michael P. Dilworth February 28, 2012.
Education Employment Procedures Law of 2001
Presentation transcript:

Go Back, Jack, Do it Again: Reissue and Reexam Patent Law

Ad law aspects of patent law Two primary features: (1) structure of administrative agency itself; and (2) court- agency review We will focus on the latter...

Hot issue today Constitutionality of PTO administrative judges’ composition

Zurko Fed Cir traditionally applied the “clearly erroneous” standard of review to PTO findings of fact Challenged in this case

Standards of review Clearly erroneous is stricter standard, allows more reversals by court, compared to “substantial evidence” standard Traditionally applied by CCPA, and then Fed Cir

At 1056 But the difference is a subtle one—so fine that (apart from the present case) we have failed to uncover a single instance in which a reviewing court conceded that use of one standard rather than the other would in fact have produced a different outcome.

APA Section 706 Section 706, originally enacted in 1946, sets forth standards that govern the “Scope” of court “review” of, e.g., agency factfinding (what we shall call court/agency review). It says that a“reviewing court shall—... “(2) hold unlawful and set aside agency... findings... found to be— “(A) arbitrary, capricious, [or] an abuse of discretion, or “(E) unsupported by substantial evidence in a case subject to sections 556 and 557 of this title or otherwise reviewed on the record of an agency hearing provided by statute;...

Arti Rai

Pre-Zurko (“clearly erroneous” standard) Post-Gartside (“substantial evidence” standard) Affirmances5768 Reversals/remands2613 Percentage affirmance 68.7%83.9% From Arti Rai, Duke Law School

Reissues Mentor v. Coloplast

251. Reissue of Defective Patents. Whenever any patent is, through error without any deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent, the Commissioner shall, on the surrender of such patent…, reissue the patent for the invention disclosed in the original patent, and in accordance with a new and amended application, for the unexpired part of the term of the original patent. No new matter shall be introduced into the application for reissue.

Key Provision “through error without any deceptive intention” – Error: mistake, inadvertence – Without deceptive intention No plan to broaden or recapture... Not the result of a strategic decision during prosecution

The Commissioner may issue several reissued patents for distinct and separate parts of the thing patented, upon demand of the applicant, and upon payment of the required fee for a reissue for each of such reissued patents. The provisions of this title relating to applications for patent shall be applicable to applications for reissue of a patent, except that application for reissue may be made and sworn to by the assignee of the entire interest if the application does not seek to enlarge the scope of the claims of the original patent.

251. Reissue of Defective Patents, cont’d No reissued patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent.

Broadening Reissues No reissued patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent. “2 Year Rule”

A reissued patent shall not abridge or affect the right of any person who …, prior to the grant of a reissue, made, purchased, offered to sell, or used within the United States, or imported into the United States, anything patented by the reissued patent, to continue the use of, to offer to sell, … unless the making, using, offering for sale, or selling of such thing infringes a valid claim of the reissued patent which was in the original patent. Intervening rights – section 252

The court before which such matter is in question may provide for the continued manufacture, use, offer for sale, or sale of the thing made, purchased, offered for sale, used, or imported as specified, or for the manufacture, use, offer for sale, or sale in the United States of which substantial preparation was made before the grant of the reissue, and the court may also provide for the continued practice of any process patented by the reissue that is practiced, or for the practice of which substantial preparation was made, before the grant of the reissue, to the extent and under such terms as the court deems equitable for the protection of investments made or business commenced before the grant of the reissue.

Reissue Requirements (1) “Error in the patent” and (2) “Error in Conduct”

Error in the Patent – Claiming too much (after- discovered prior art) – Not claiming enough (after- discovered competitor product)

Some Defects are too Big! Complete anticipation Insufficient disclosure

Rules cont’d Error in conduct – Reissue cures only some types of conduct Cannot cure Inequitable conduct, e.g.

The two-year period is not based on the priority date but on the issue date. 35 U.S.C. § 251; M.P.E.P. ¶ Accordingly, a broadening reissue may be filed on a continuation or divisional application more than two years after the issue date of the parent patent so long at it is filed within two years of the issue date of the continuation patent.

Mentor v. Coloplast Why did Mentor seek a reissue? How did this relate to its litigation strategy?

“An attorney’s failure to appreciate the full scope of the invention” is not an uncommon defect in claiming an invention. In re Wilder, 736 F.2d 1516, 222 U.S.P.Q. 369 (Fed. Cir. 1984), cert. denied, 469 U.S (1985).

Mentor v. Coloplast Recapture rule – Only applies to broadened reissue claims Cannot recapture subject matter surrendered in original prosecution Nuanced application: claims broader in some ways than original, narrower than in original

Mentor’s initial claims, which did not require the transfer of the adhesive from the outer to the inner catheter surface, were rejected by the examiner. Mentor then added the adhesive transfer limitation and argued that the amended claims should be allowed because “none of the references relied upon actually showed the transfer of adhesive from the outer surface to the inner surface as the sheath is rolled up and then unrolled.” The amended claims were allowed. Mentor then sought and obtained the reissue patent containing claims 6-9.

p Reissue claim 6, which does not include the adhesive transfer limitation, impermissibly recaptures what Mentor deliberately surrendered in the original prosecution. Specifically, the reissue claims do not contain the limitation that, during rolling and unrolling, the adhesive be transferred from the outer to the inner surface of the catheter.

Medrad, Inc. v. Tyco Healthcare Group LP, 466 F.3d 1047 (Fed. Cir. 2006) Failure to submit proper declaration and oath with original reissue was correctable in a second reissue request

Reissue vs. Reexam Reissue: available to fix patent for any cause that makes it “inoperative or invalid”; can be broadening (2 yr rule) Only the patentee may request reissue Can be withdrawn by patentee at any time

Reexam Can be requested by anyone The types of prior art which may be considered in a reexamination proceeding are limited to patents and printed publications. 35 U.S.C. § 301; 37 C.F.R. § 1.552

Traditional (Ex Parte) Reexams Third party participation in a traditional reexamination is limited. If a third party requests reexamination, the patent owner is notified and provided an opportunity to submit a statement in opposition to an order for reexamination. 35 U.S.C. § 302; 37 C.F.R. §§ 1.510(b)(5), 1.530(b).

If the patent owner submits a statement, the requestor is given an opportunity to reply. 37 C.F.R. § Otherwise, a non-patentee requestor's participation ends with the request for reexamination. However, the patentee is required to serve on the requestor a copy of all papers filed with the Patent Office. 37 C.F.R. § 1.550(e).

35 U.S.C. 301 Citation of prior art. Any person at any time may cite to the Office in writing prior art consisting of patents or printed publications which that person believes to have a bearing on the patentability of any claim of a particular patent. If the person explains in writing the pertinency and manner of applying such prior art to at least one claim of the patent, the citation of such prior art and the explanation thereof will become a part of the official file of the patent.

Section 302.Request for Reexamination Any person at any time may file a request for reexamination by the Office of any claim of a patent on the basis of any prior art cited under the provisions of Section 301 of this title. The request must be in writing and must be accompa­nied by payment of a reexamination fee established by the Commissioner of Patents pursuant to the provisions of Section 41 of this title. The request must set forth the pertinency and manner applying cited prior art to every claim for which reexamination is requested. Unless the requesting person is the owner of the patent, the Commissioner promptly will send a copy of the request to the owner of record of the patent.

What is required? 303 (a): Within three months following the filing of a request for reexamination under the provisions of section 302 of this title, the Director will determine whether a substantial new question of patentability affecting any claim of the patent concerned is raised by the request, with or without consideration of other patents or printed publications

Quantum v. Rodime

Page 1095 Rodime requested reexamination and, during the ensuing proceedings, amended the track density limitation from “at least 600” to “at least approximately 600” tpi

35 U.S.C. § 305 states, in relevant part, that “[n]o proposed amended or new claim enlarging the scope of a claim of the patent will be permitted in a reexamination proceeding.”...

The term “at least approximately 600 tpi” therefore defines an open-ended range starting slightly below 600. Since the amended limitation includes subject matter not covered by the original claims, i.e. track densities below 600 tpi, we conclude that Rodime expanded the scope of their claims during reexamination in violation of 35 U.S.C. § 305.

Inter partes reexam Rationale Complaints Reform?

Patent Quality Control ex parte inexpensive inter partes Administrative Patent Revocation? expensive inter partes moderately inexpensive low quality high quality good quality

Complaints, reform Under Section 315(c) of the Patent Act, a third party that requests inter partes reexamination is estopped from later raising the same issues in a court proceeding. The proposed Patent Act of 2008 would change the estoppel provision and would allow inter partes reexams to apply to all patents (rather than only those filed since 1999).

On the increase? Year Ending: Number of Filings June : 4 June : 18 June : 26 June : 52